The pharmaceutical industry continues to evolve, bringing innovative treatments to millions of Americans while driving significant economic growth. In 2024, the top-selling prescription drugs in the US

Humira, the brand name for adalimumab, is a biologic medication widely used to manage various autoimmune and inflammatory conditions. Approved by the FDA in 2002, Humira belongs to a class